Operator

Good morning. My name is Tina, and I will be your operator today. At this time, I would like to welcome everyone to the IMUNON First Quarter 2026 Final Results Conference Call. [Operator Instructions]

I would now like to turn the call over to Brandon Weiner of ICR Healthcare Investor Relations, representative of IMUNON. Please go ahead.

Brandon Weiner

Thank you. Good morning, everyone, and welcome to IMUNON's First Quarter 2026 Financial Results and Business Update Conference Call.

During today's call, management will be making forward-looking statements regarding IMUNON's expectations and projections about future events. In general, forward-looking statements can be identified by words such as expects, anticipates, believes or other similar expressions. These statements are based on current expectations and are subject to a number of risks and uncertainties, including those set forth in the company's periodic filings with the Securities and Exchange Commission. No forward-looking statements can be guaranteed, and actual results may differ materially from such statements.

I also caution that the content of this conference call is accurately is accurate only as of the date of the live broadcast, May 12, 2026. IMUNON undertakes no obligation to revise or update comments made during this call, except as required by law.

With that said, I would like to turn the call over to Dr. Stacy Lindborg, IMUNON's President and Chief Executive Officer. Stacy?